GlassScriptPhysician profile
Jennifer D Ocampo
NPI 1043792179
$2,664.26
in general payments reported to CMS, 2019-2025
24 companies · $1,731 in 2025
The $1,731 reported for 2025 was more than what 98% of Pediatrics (Nurse Practitioner) providers received nationally (typical 2025 total: $93.49).
See the full distribution for Pediatrics (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $35.78 · 2022: $131 · 2023: $452 · 2024: $315 · 2025: $1,731.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,498.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,497.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $580.90 | 2022-2025 | Bexsero, Arexvy, Shingrix |
| Cranial Technologies, INC | $370.45 | 2024-2025 | Doc Band |
| Sanofi Pasteur INC. | $167.62 | 2025 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $143.57 | 2025 | Caplyta |
| Bayer Healthcare Pharmaceuticals INC. | $137.97 | 2025 | |
| Merck Sharp & Dohme LLC | $133.86 | 2021-2025 | Enflonsia, Gardasil 9, Vaxelis |
| Lilly USA, LLC | $124.99 | 2025 | Mounjaro |
| Amgen INC. | $124.70 | 2023 | Evenity |
| Kyowa Kirin, INC. | $120.87 | 2025 | |
| Novo Nordisk INC | $119.99 | 2025 | Sogroya |
| Verrica Pharmaceuticals INC. | $111.22 | 2025 | Ycanth |
| Sanofi-Aventis U.S. LLC | $106.09 | 2025 | |
| Phadia US INC. | $86.31 | 2021-2022 | |
| Dynavax Technologies Corporation | $74.53 | 2023-2025 | Heplisav-B |
| Pfizer INC. | $41.91 | 2025 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Viiv Healthcare Company | $36.50 | 2023 | Apretude |
| Lundbeck LLC | $35.78 | 2025 | Abilify Asimtufii |
| Shield Therapeutics INC | $25.41 | 2025 | |
| Boston Scientific Corporation | $24.14 | 2022 | |
| Exact Sciences Corporation | $24.06 | 2024 | Cologuard Collection Kit |
| Hologic Sales and Service, LLC | $23.71 | 2025 | Aptima |
| Otsuka America Pharmaceutical, INC. | $18.16 | 2025 | Rexulti |
| Qiagen, LLC | $16.53 | 2025 | |
| E.R. Squibb & Sons, L.L.C. | $14.99 | 2025 | Cobenfy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jennifer Ocampo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.